Literature DB >> 26799344

Fifty years of pharmacovigilance - Medicines safety and public health.

Joan-Ramon Laporte1.   

Abstract

Mesh：

Year:  2016        PMID： 26799344     DOI： 10.1002/pds.3967

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  4 in total

Review 1.  Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.

Authors:  Emilie Patras de Campaigno; Emmanuelle Bondon-Guitton; Guy Laurent; Francois Montastruc; Jean-Louis Montastruc; Maryse Lapeyre-Mestre; Fabien Despas
Journal:  Br J Clin Pharmacol       Date:  2017-02-14       Impact factor: 4.335

2.  Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works.

Authors:  Aniello Santoro; Georgy Genov; Almath Spooner; June Raine; Peter Arlett
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

3.  Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP).

Authors:  Xavier Kurz; Susana Perez-Gutthann
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-01-11       Impact factor: 2.890

4.  Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.

Authors:  Thomas Goedecke; Daniel R Morales; Alexandra Pacurariu; Xavier Kurz
Journal:  Br J Clin Pharmacol       Date:  2017-12-20       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.